NASDAQ: THRM

Gentherm Inc

CIK 0000903129 · SIC 3714 · Motor Vehicle Parts & Accessories

Mid Revenue $1.5B Assets $1.5B as of Sep 27, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (SAR 10-Q) is open in full — no account needed.

8-K Filed Oct 1, 2026 · Period ending Sep 29, 2026

Summary not yet generated.

8-K Filed Sep 11, 2026 · Period ending Sep 10, 2026

Summary not yet generated.

Partner

Trade THRM commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

424B3 Filed Aug 12, 2026 Red flag

Gentherm to acquire Modine's Performance Technologies Business for ~20.8M shares in reverse Morris Trust, diluting existing shareholders by 40%

9 material changes detected. Sign up free to read the summary.

8-K Filed Jul 23, 2026 · Period ending Jul 23, 2026

Gentherm raises FY2026 guidance, authorizes up to $400M buyback replacing up to $150M program

5 material changes detected. Sign up free to read the summary.

10-Q Filed Jul 23, 2026 · Period ending Jun 30, 2026 Red flag

revenue $416.2M, net income $4.4M. Gentherm revenue +11% but operating income -55% on Modine M&A costs; warranty accrual triples

5 material changes detected. Sign up free to read the summary.

8-K Filed Jul 2, 2026 · Period ending Jun 29, 2026

Gentherm enters $550M 5-year revolving credit facility with leverage-based pricing

4 material changes detected. Sign up free to read the summary.

8-K Filed May 19, 2026 · Period ending May 14, 2026

Gentherm shareholders approve 1.7M share increase to equity incentive plan

5 material changes detected. Sign up free to read the summary.

10-Q Filed Apr 23, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

8-K Filed Apr 23, 2026 · Period ending Apr 23, 2026

Summary not yet generated.

8-K Filed Mar 25, 2026 · Period ending Mar 24, 2026

Summary not yet generated.

10-K Filed Feb 19, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-Q Filed Oct 23, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-Q Filed Jul 24, 2025 · Period ending Jun 30, 2025

Summary not yet generated.

10-K Filed Feb 19, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

Latest financial statements

From 10-Q filed Jul 23, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Consolidated Condensed Statements of Income (Unaudited)

(In thousands, except per share data)

Description Three months ended June 30, 2026 Three months ended June 30, 2025 Six months ended June 30, 2026 Six months ended June 30, 2025
Product revenues 416,166 375,090 809,872 728,944
Cost of sales 319,739 285,328 616,218 552,717
Gross margin 96,427 89,762 193,654 176,227
Operating expenses:
Net research and development expenses 24,069 22,558 48,015 46,774
Selling, general and administrative expenses 55,705 41,087 111,010 79,565
Restructuring expenses, net 5,964 2,108 12,655 6,622
Loss on sale of land and building, net — — — 2,196
Total operating expenses 85,738 65,753 171,680 135,157
Operating income 10,689 24,009 21,974 41,070
Interest expense, net (3,290) (4,043) (5,923) (7,598)
Foreign currency loss (237) (17,432) (1,297) (27,730)
Other income (loss) 162 — 184 (1,124)
Earnings before income tax 7,324 2,534 14,938 4,618
Income tax expense 2,904 2,057 6,300 4,269
Net income 4,420 477 8,638 349
Basic earnings per share 0.14 0.02 0.28 0.01
Diluted earnings per share 0.14 0.02 0.28 0.01
Weighted average number of shares basic 30,650 30,600 30,584 30,687
Weighted average number of shares diluted 31,054 30,652 30,947 30,781

Consolidated Condensed Balance Sheets (Unaudited)

(In thousands, except share data)

Description June 30, 2026 December 31, 2025
ASSETS
Current Assets:
Cash and cash equivalents 213,173 160,833
Accounts receivable, net 338,851 281,083
Inventory:
Raw materials 116,549 128,314
Work in process 37,913 35,429
Finished goods 90,076 88,959
Inventory, net 244,538 252,702
Other current assets 83,451 82,332
Total current assets 880,013 776,950
Property and equipment, net 268,780 270,614
Goodwill 107,111 108,918
Other intangible assets, net 49,703 52,796
Operating lease right-of-use assets 50,794 56,524
Deferred income tax assets 92,957 93,552
Other non-current assets 43,846 37,075
Total assets 1,493,204 1,396,429
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Accounts payable 270,382 260,487
Current lease liabilities 8,199 9,646
Current maturities of long-term debt 868 73
Other current liabilities 146,832 134,104
Total current liabilities 426,281 404,310
Long-term debt, less current maturities 272,390 189,000
Non-current lease liabilities 43,623 48,105
Pension benefit obligation 3,313 3,748
Other non-current liabilities 24,479 30,943
Total liabilities 770,086 676,106
Shareholders’ Equity:
Common Stock:
No par value; 55,000,000 shares authorized 30,705,208 and 30,526,231 issued and outstanding at June 30, 2026 and December 31, 2025, respectively 10,709 5,611
Paid-in capital 1,590 1,590
Accumulated other comprehensive loss (11,905) (964)
Accumulated earnings 722,724 714,086
Total shareholders’ equity 723,118 720,323
Total liabilities and shareholders’ equity 1,493,204 1,396,429

Consolidated Condensed Statements of Cash Flows (Unaudited)

(In thousands)

Description Six months ended June 30, 2026 Six months ended June 30, 2025
Operating Activities:
Net income 8,638 349
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 28,744 26,089
Deferred income taxes (8,676) (12,202)
Stock based compensation 7,446 6,604
Loss on disposition of property and equipment 246 2,444
Provisions for inventory 2,425 3,213
Other non-cash items, including unrealized foreign currency (gain) loss 1,456 31,364
Changes in assets and liabilities:
Accounts receivable, net (58,121) (23,690)
Inventory (4,379) (13,430)
Other assets (3,816) (23,102)
Accounts payable 16,224 20,522
Other liabilities 12,085 13,540
Net cash provided by operating activities 2,272 31,701
Investing Activities:
Purchases of property and equipment (14,203) (23,728)
Proceeds from the sale of property and equipment 70 3,745
Proceeds from deferred purchase price of factored receivables — 744
Cost of technology investments (250) (590)
Net cash used in investing activities (14,383) (19,829)
Financing Activities:
Borrowings on debt 142,000 52,000
Repayments of debt (71,072) (63,076)
Cash paid for financing new loans (2,761) —
Taxes withheld and paid on employees' stock based compensation (2,302) (1,238)
Cash paid for the repurchase of Common Stock — (10,015)
Net cash provided by (used in) financing activities 65,865 (22,329)
Foreign currency effect (1,414) 4,620
Net increase (decrease) in cash and cash equivalents 52,340 (5,837)
Cash and cash equivalents at beginning of period 160,833 134,134
Cash and cash equivalents at end of period 213,173 128,297
Supplemental disclosure of cash flow information:
Cash paid for interest 5,774 6,757
Non-Cash Investing Activities:
Period-end balance of accounts payable for property and equipment 3,287 6,645

Amounts as printed on the EDGAR/iXBRL face — (In thousands, except per share data); (In thousands, except share data); (In thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

View AI report for this filing